https://pubmed.ncbi.nlm.nih.gov/38654416/
Shifting patterns of multiple sclerosis treatment in a highly prevalent United States population
MS is highly prevalent in a representative Colorado cohort. Overall treatment and proportion of highly effective therapy exposure increased significantly...
multiple sclerosis treatment
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0217208
Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment | PLOS One
Multiple sclerosis (MS) treatment options have improved significantly over the past decades, but the consequences of MS can still be devastating and the needs...
multiple sclerosis treatment
https://health.economictimes.indiatimes.com/news/hospitals/oral-medication-leading-choice-for-multiple-sclerosis-treatment-study/102043036
Oral medication leading choice for multiple sclerosis treatment: Study, ETHealthworld
Oral Medication: "While two injectable therapies known as platform injectables, were once the mainstay of multiple sclerosis treatment, our study showed oral...
multiple sclerosis treatmentoral medicationleadingchoicestudy
https://about.uq.edu.au/experts/project/15421
Treatment of Multiple Sclerosis with parasite immunomodulatory molecules | Project | UQ Experts
multiple sclerosistreatment
https://researchconnect.buffalo.edu/en/publications/what-is-new-in-the-treatment-of-multiple-sclerosis/
What is new in the treatment of multiple sclerosis? - SUNY University at Buffalo
what is new
https://larivebio.com/
Treatment solution in Multiple Sclerosis | LaRive Bio AG
Focus of LaRive Bio is on licensing / acquiring, development with abbreviated pathway and out-licensing of new molecules for significant unmet medical need. ....
multiple sclerosistreatmentsolutionlarivebio
https://www.sciencedaily.com/releases/2017/06/170601124019.htm
Common acne medication offers new treatment for multiple sclerosis | ScienceDaily
A research team has published important research which will benefit individuals who are in the early stages of multiple sclerosis (MS). Their study results...
acne medicationoffers newtreatment formultiple sclerosiscommon
https://eprints.ncl.ac.uk/69853
The way forward to treatment optimisation in multiple sclerosis: Introduction - ePrints - Newcastle...
the way forward
https://portal.fis.tum.de/en/publications/interferon-beta-treatment-does-not-induce-organ-specific-autoanti/
Interferon beta treatment does not induce organ-specific autoantibodies in multiple sclerosis -...
does not
https://publikationen.uni-tuebingen.de/xmlui/handle/10900/116271
Ocrelizumab Treatment in Patients with Primary Progressive Multiple Sclerosis: Short-term Safety...
in patients
https://www.lemtrada.com/
Relapsing Multiple Sclerosis (MS) Treatment | LEMTRADA® (alemtuzumab) IV 12mg
Explore LEMTRADA® (alemtuzumab), an infusion therapy for relapsing forms of multiple sclerosis (MS). Learn about dosing, treatment schedules and more. See...
relapsing multiple sclerosismstreatmentalemtuzumabiv
https://pubmed.ncbi.nlm.nih.gov/28988546/
The Impact of Health Anxiety in Multiple Sclerosis: A Replication and Treatment Case Series
Given the high rates of HA in MS patients and its impact on QoL, this case series suggests that a brief CBT intervention could significantly improve patients'...
https://ectrims.eu/
European Committee for Treatment and Research in Multiple Sclerosis | ECTRIMS
Jul 16, 2026 - The world’s largest professional organisation dedicated to the understanding and treatment of multiple sclerosis.
treatment and researcheuropean committeemultiple sclerosisectrims
https://www.cochrane.org/evidence/CD007295_drug-treatment-depression-multiple-sclerosis
Drug treatment for depression in multiple sclerosis | Cochrane
treatment for depressionmultiple sclerosisdrugcochrane